West Pharmaceutical Services Inc (NYSE:WST)
$ 331.66 3.07 (0.93%) Market Cap: 24.16 Bil Enterprise Value: 23.64 Bil PE Ratio: 43.75 PB Ratio: 9.03 GF Score: 95/100

West Pharmaceutical Services Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 04, 2019 / 06:00PM GMT
Release Date Price: $147.93 (+2.11%)
Michael K. Polark;Quintin J. Lai
Robert W. Baird & Co. Incorporated, Research Division - Research Associate;West Pharmaceutical Services, Inc. - VP of Corporate Development,

All right. Good. We can go ahead and get started. Good afternoon, everyone. My name is Mike Polark, I am on the healthcare supply chain and pharma services research team here at Baird. We're pleased to welcome West Pharmaceutical to the conference again this year.

With the company, we have CFO, Bernard Birkett; and we have VP of Corporate Development, Strategy and IR, Quintin Lai.

West, as you may know, is a global manufacturer of proprietary products used primarily for the containment and delivery of injectable drugs. The company also has a contract manufacturing business focused on complex devices.

Quintin is going to do some prepared remarks, and we will have plenty of time for Q&A at the end. So if you do have any questions, we can do a raise of hands or [email protected] and I'll be happy to coordinate.

So with that, I will turn it over to Quintin.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot